NVL
Basic information
Region (hg38): 1:224227334-224330189
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NVL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 25 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 4 | 0 |
Variants in NVL
This is a list of pathogenic ClinVar variants found in the NVL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-224227651-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
1-224227652-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
1-224233216-T-C | not specified | Uncertain significance (Dec 30, 2023) | ||
1-224233246-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
1-224250292-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
1-224268091-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
1-224275343-C-T | not specified | Uncertain significance (Nov 15, 2024) | ||
1-224275372-C-T | Likely benign (Aug 01, 2022) | |||
1-224275374-C-T | not specified | Uncertain significance (Nov 08, 2024) | ||
1-224275415-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
1-224281155-T-G | not specified | Uncertain significance (Sep 09, 2024) | ||
1-224287806-T-A | not specified | Uncertain significance (Apr 26, 2024) | ||
1-224287942-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
1-224287957-G-C | not specified | Uncertain significance (Sep 23, 2023) | ||
1-224289599-T-C | not specified | Likely benign (Feb 05, 2024) | ||
1-224289650-A-G | not specified | Uncertain significance (Oct 29, 2024) | ||
1-224289693-C-T | not specified | Likely benign (Nov 03, 2023) | ||
1-224289698-G-A | not specified | Uncertain significance (Dec 30, 2023) | ||
1-224294303-A-G | not specified | Uncertain significance (Nov 03, 2022) | ||
1-224294309-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
1-224294347-C-T | Likely benign (Apr 01, 2022) | |||
1-224294355-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
1-224294385-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
1-224296576-T-C | not specified | Uncertain significance (Feb 07, 2023) | ||
1-224300582-C-T | not specified | Uncertain significance (Sep 08, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NVL | protein_coding | protein_coding | ENST00000281701 | 23 | 103054 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.26e-19 | 0.656 | 125636 | 0 | 111 | 125747 | 0.000441 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.59 | 366 | 462 | 0.792 | 0.0000242 | 5560 |
Missense in Polyphen | 108 | 174.09 | 0.62037 | 1935 | ||
Synonymous | 0.394 | 158 | 164 | 0.961 | 0.00000836 | 1680 |
Loss of Function | 2.01 | 37 | 52.7 | 0.702 | 0.00000325 | 587 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00110 | 0.00110 |
Ashkenazi Jewish | 0.000794 | 0.000794 |
East Asian | 0.000770 | 0.000598 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000344 | 0.000343 |
Middle Eastern | 0.000770 | 0.000598 |
South Asian | 0.000590 | 0.000588 |
Other | 0.000815 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in the assembly of the telomerase holoenzyme and effecting of telomerase activity via its interaction with TERT (PubMed:22226966). Involved in both early and late stages of the pre-rRNA processing pathways (PubMed:26166824). Spatiotemporally regulates 60S ribosomal subunit biogenesis in the nucleolus (PubMed:15469983, PubMed:16782053, PubMed:29107693, PubMed:26456651). Catalyzes the release of specific assembly factors, such as WDR74, from pre-60S ribosomal particles through the ATPase activity (PubMed:29107693, PubMed:26456651, PubMed:28416111). {ECO:0000269|PubMed:15469983, ECO:0000269|PubMed:16782053, ECO:0000269|PubMed:22226966, ECO:0000269|PubMed:26166824, ECO:0000269|PubMed:26456651, ECO:0000269|PubMed:28416111, ECO:0000269|PubMed:29107693}.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.127
- rvis_EVS
- 0.56
- rvis_percentile_EVS
- 81.67
Haploinsufficiency Scores
- pHI
- 0.104
- hipred
- Y
- hipred_score
- 0.590
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.701
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nvl
- Phenotype
Gene ontology
- Biological process
- rRNA processing;positive regulation of protein binding;ribosome biogenesis;ribosomal large subunit biogenesis;positive regulation of telomerase activity;regulation of protein localization to nucleolus
- Cellular component
- nuclear exosome (RNase complex);nucleus;nucleoplasm;telomerase holoenzyme complex;nucleolus;membrane
- Molecular function
- RNA binding;protein binding;ATP binding;ATPase activity;preribosome binding